Schonfeld Strategic Advisors LLC

Position in ABOS — Acumen Pharmaceuticals, Inc.

CIK 1665241 NEW YORK, NY

Position in ABOS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$26,668

+$8,191 QoQ

Shares Held

11,300

-29.1% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#58

of 84 holders

Holding Since

Dec 2021

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Schonfeld Strategic Advisors LLC holds $295,816,121 across 125 Biotechnology names. ABOS ranks #118 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FOLD	AMICUS THERAPEUTICS, INC.	1,757,899	$25,419,219
2	ALNY	Alnylam Pharmaceuticals, Inc.	71,767	$23,745,547
3	PTCT	Ptc Therapeutics, Inc.	318,405	$21,692,932
4	XENE	Xenon Pharmaceuticals Inc.	324,722	$18,882,584
5	INBX	Inhibrx Biosciences, Inc.	254,827	$17,132,019
6	JAZZ	Jazz Pharmaceuticals plc	62,142	$11,747,945
7	RARE	Ultragenyx Pharmaceutical Inc.	494,737	$10,364,740
8	INSM	INSMED Inc	56,056	$9,166,277

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$26,668	11,300	-29.1%	Shares	Sole	2026-05-15
2025-06-30	$18,477	15,929	-78.4%	Shares	Sole	2025-08-14
2024-06-30	$178,157	73,619	-83.9%	Shares	Sole	2024-08-14
2024-03-31	$1,856,860	458,484	-18.4%	Shares	Sole	2024-05-15
2023-12-31	$2,156,321	561,542	-13.0%	Shares	Sole	2024-02-14
2023-09-30	$2,677,214	645,112	+323.2%	Shares	Sole	2023-11-14
2022-09-30	$1,528,862	152,429	+31.4%	Shares	Sole	2022-11-14
2022-06-30	$545,336	116,029	+34.1%	Shares	Sole	2022-08-15
2022-03-31	$338,383	86,543	0.0%	Shares	Sole	2022-05-16
2021-12-31	$585,030	86,543	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.